Jason Trubiano
@trubianojason.bsky.social
1.8K followers 510 following 35 posts
Prof/Director of Infectious Diseases & Immunology @austin_health. UoM Research Fellow @ID_austin @CAAR_Aus @TheDohertyInst @UniMelbMDHS #AMS #AMR #penicillinallergy #drugallergy #TID
Posts Media Videos Starter Packs
Pinned
trubianojason.bsky.social
My Top 5 Antibiotic Allergy Papers.... #IDSky #MedSky #Penicillinallergy #Antibioticallergy.
trubianojason.bsky.social
My Top 5 Antibiotic Allergy Papers - #5
▶️Gadde et al. JAMA 1993; 270 (20)
▶️ A paper before its time. Skin testing for #penicillinallergy in patients with ID indication!
▶️ 7.1% + ; PPL & MDM utilisation; safety (1/128+ required adrenaline); Allergy LOSS WITH TIME.
jamanetwork.com/journals/jam...
Clinical Experience With Penicillin Skin Testing in a Large Inner-City STD Clinic
Objective.  —To establish (1) the prevalence of positive penicillin skin tests among outpatients with well-defined but variable history of penicillin allergy and (2) the reproducibility, safety, a...
jamanetwork.com
trubianojason.bsky.social
Congratulations Elise Mitri from NACE, Austin Health & The Peter Doherty Institute presenting the iNAAN Trial results - > 5000 pts & 1500 inpatient #penicillinallergy DOC performed. Safe irrespective of stakeholder with significant prescribing gains. Largest inpatient penicillin allergy study 👏🎉
trubianojason.bsky.social
Is one dose enough?! Great talk from Dr Rose for the #PROSPECTOR #penicillinallergy #RCT at #EAACI HK Summer School. 6.7% increase in immune mediated reactions with prolonged oral challenge. Looking forward to #PROSPECTOR2 definitive phase III study to change practice!
trubianojason.bsky.social
Excited to be at EAACI Hong Kong School 2025 Hosted by Prof Li. Can’t wait for Elise Mitri from The Peter Doherty Institute to present the #iNAAN Results - #PenicillinAllergy #delabing Global Implementation! Dr Rose will present #PROSPECTOR1 - is one dose enough to delabel penicillin allergy?!? ‼️👀
trubianojason.bsky.social
Thank you @eurekaprizes.bsky.social for the opportunity and my research team Austin Health & Doherty Institute for driving the research in #antibioticallergy #EurekaPrizes
eurekaprizes.bsky.social
Professor @trubianojason.bsky.social is a finalist in the Eureka Prize for Emerging Leader in Science.

Learn more: youtu.be/qaPw-YsXix4

#EurekaPrizes
trubianojason.bsky.social
Can’t say no to that!
trubianojason.bsky.social
Another validation of SULF-FAST form Canadian data about to drop! 🎤
trubianojason.bsky.social
#ESCMIDGlobal #FOMO…. Watching online the amazing @elisemitri.bsky.social and thanks to @cmicomms.bsky.social for publishing this work! Not missing another #ESCMIDGlobal!!
angelahuttner.bsky.social
Congrats to @elisemitri.bsky.social, @trubianojason.bsky.social et al for their great work on safely delabeling patients with #penicillinallergy. Elise presenting their prospective, pharmacist-led program live at #ESCMIDGlobal
#IDSky #PharmSky #openacess

www.cmi-comms.com/article/S295...
Elise Mitri presenting work on safely delabeling patients with penicillin allergy at the ESCMID Global conference.
trubianojason.bsky.social
Hopefully can get a # going for the conference - #ASID2025 ? Get some of the proffered papers and new research out from #EMCR #IDResearch #Infectiousdiseases
trubianojason.bsky.social
Follow our 🇦🇺🇳🇿 ID Society #ASID asidaud.bsky.social 🏆 Great to see you on #bsky 👏
asidaud.bsky.social
asidaud.bsky.social
trubianojason.bsky.social
Follow our 🇦🇺🇳🇿 ID Society #ASID asidaud.bsky.social 🏆 Great to see you on #bsky 👏
asidaud.bsky.social
asidaud.bsky.social
Reposted by Jason Trubiano
asidaud.bsky.social
ASID Annual Scientific Meeting kicked off yesterday in Canberra. The pre-conference workshop hosted by Therapeutic Guidelines Australia attracted over 120 attendees and was a very engaging and informative session. The formal program commences tomorrow in what will be one of the largest ASM’s.
trubianojason.bsky.social
We randomised our first patients yesterday into the #PROSPECTOR2 ⛏️ study - international superioty trail of 1 dose versus day challenge for #penicillinallergy. “Is one dose ever enough….”
trubianojason.bsky.social
Best thing about #AAAAI25 is the start of the #JPCoffeeTour! #SanDiego #DrugAllergyChat
trubianojason.bsky.social
Loved this ❤️ Talk of the #drugallergy town!
trubianojason.bsky.social
1000 direct oral #penicillinallergy challenges in the prospective iNAAN study 🎉- 39 hospitals and 7 countries 😳. The largest adult penicillin challenge study! Well done @elisemitri.bsky.social 👏👏 and all collaborators! @escmid.bsky.social data coming hopefully to #ESCMIDglobal 2025!
Reposted by Jason Trubiano
steventong.bsky.social
The incredibly impressive Ouli Xie is presenting his PhD completion seminar on Monday Nov 25 at 12.30pm AEDT.

"The clinical, epidemiological, and evolutionary intersection between Streptococcus dysgalactiae subspecies equisimilis and Streptococcus pyogenes"

unimelb.zoom.us/j/8944229688...?
Join our Cloud HD Video Meeting
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom ...
unimelb.zoom.us
Reposted by Jason Trubiano
seanong.bsky.social
Feels right that my 1st post here should be to share this incredible RCT, led by my PhD supervisor Nick Daneman:

www.nejm.org/doi/full/10....

Main takeaway: 7-days of abx should be the standard of care for patients with uncomplicated non-S. aureus BSI.

A deep dive 🧵:

#IDsky
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections | NEJM
Bloodstream infections are associated with substantial morbidity and mortality. Early, appropriate antibiotic therapy is important, but the duration of treatment is uncertain. In a multicenter, non...
www.nejm.org
Reposted by Jason Trubiano
gurujosh.bsky.social
Hi #IDSky! I’m putting together my usual top 10 ID papers of this year list again (this time will post here not in the other world).

Please tell me your candidate papers - practice changing paradigm shifting or dogma challenging!
trubianojason.bsky.social
#WAAW kicking off at @ncas.bsky.social symposium today 🇦🇺. Looking forward to a great program and a lot of representation from team #AustinHealth #AMS #DrugAllergy